K-numberK253489
Device nameSwoop® Portable MR Imaging® System
ApplicantHyperfine, Inc.
Product codeLNH
Device classClass II
Decision dateDec 12, 2025
DecisionSubstantially Equivalent
Regulation892.1000
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Swoop Portable MR Imaging System is a portable, ultra-low field magnetic resonance imaging device designed to visualize internal head structures where full diagnostic examination is not clinically practical. When interpreted by a trained physician, the images provide information useful in determining diagnosis in adult and pediatric patients (≥0 years) in point-of-care settings such as emergency rooms, intensive care units, hospitals, and outpatient facilities.

Technological characteristics

The subject device maintains the same magnet type (permanent magnet at 63.3±2.0 mT or 64.9 mT nominal), patient bore dimensions, gradient system specifications, and RF coil design as the predicates. The primary modification is software enhancements to pulse sequences (T1W, T2W, FLAIR, DWI) utilizing deep learning-based image reconstruction algorithms to improve image quality, while maintaining identical operational parameters, patient weight capacity (1.6–200 kg), and anatomical focus (head imaging only).

Test standards cited

Testing was performed per IEC 62304:2016 (software verification), NEMA MS 1-2008, MS 3-2008, MS 9-2008, MS 12-2016 (image performance), ISO 10993-1:2018 and ISO 10993-5:2009 (biocompatibility), ANSI/AAMI ES 60601-1:2005 and IEC 60601-1-2:2014 (electrical safety and EMC), FDA guidance on cybersecurity and software functions, and American College of Radiology standards for named sequences.

Substantial equivalence argument

The subject device is substantially equivalent to predicates K250236 (Model 2) and K251276 (Model 1) because it shares identical intended use, patient population, anatomical site, energy modality, and hardware specifications. The software modifications to pulse sequences do not introduce new safety or efficacy concerns; testing demonstrates that advanced reconstruction preserves pathology contrast, improves image quality metrics, and maintains diagnostic consistency compared to linear reconstruction across multiple sequence types and pathologies.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →